Postgrad LIVE! Study Fairs

Southampton | Bristol

University of Leeds Featured PhD Programmes
Imperial College London Featured PhD Programmes
Ulster University Featured PhD Programmes
University of Glasgow Featured PhD Programmes
University of Nottingham Featured PhD Programmes

Two New PhD Scholarships at the Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law

  • Funded PhD Programme (Students Worldwide)
    Funded PhD Programme (Students Worldwide)

About This PhD Profile

Profile Description

The Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) explores the legal challenges and the rapid developments in the biotechnological area. CeBIL brings together scholars from some of the world's leading research institutions in interdisciplinary collaboration as well as stakeholders from industry, government and civil society. Alongside other projects, CeBIL hosts the Collaborative Research Programme for Biomedical Innovation Law (CeBIL Programme). This 5-year research programme (2018-22) is supported by a grant of DKK 35 million from the Novo Nordisk Foundation and involves partners from Cambridge, Harvard Law School, Harvard Medical School, Michigan, and the UCPH IFRO.

The CeBIL Programme focuses on innovation inefficiencies on the life science frontiers through five concrete interrelated studies. The common aim of the five studies is to optimise legal concepts into enabling tools that will help bring novel technologies, research, and biomedicine together for radical innovation – thereby providing much-needed contribution to bridging bio-pharmaceutical innovation gaps, enhancing translational medicine, and promoting technology transfer.

An overarching study on Policy & Synergy will ensure continuous knowledge exchange and synergy across the five concrete studies:

1. Antibiotics Study
2. Orphan Drugs Study
3. Precision Medicine Study
4. New Uses Study
5. Drug Manufacturing & Biologics Study
6. Policy & Synergy

The objective of the CeBIL Programme is to demonstrate how legal science methods that take careful account of interdisciplinary insights and “real world” perspectives can generate new knowledge about key factors driving pharmaceutical innovation. In addition, such methods will be utilised to examine how innovation incentives, other than patents, can be applied, combined, optimised and conceptualised in order to either substitute or complement patent protection in new areas of crucial medical applications.

The two PhD researchers are meant to be included in Study 1 (Antibiotics) and Study 6 (Policy & Synergy).

The CeBIL management, however, reserves the right to recruit candidates for one of the other four studies instead, should their academic profile and research plan provide an even better fit for the CeBIL Programme as a whole.

Read the official PhD Scholarship posting here:

Deadline: 1 December 2018 Start of employment: 1 May 2019

Funding Notes

Some or all of the PhD opportunities in this programme have funding attached. Applications for this programme are welcome from suitably qualified candidates worldwide. Funding may only be available to a limited set of nationalities and you should read the full programme details for further information.

Related Subjects

FindAPhD. Copyright 2005-2019
All rights reserved.